An annual state-of-the-industry report by Massachusetts’ main biotech trade group is full of unwelcome news to developers, investors and lenders exposed to the state’s life science real estate market.
Total employment in the Massachusetts life sciences industry remained effectively flat in 2024, a key source of pressure for lab landlords.
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
Two Democrats who have a chance to stamp their mark on Gov. Maura Healey’s $3.5 billion plan to reinvigorate the state’s business climate want the benefits to stretch beyond the Boston metropolitan area.
A Lawrence buyer snapped up an Andover office building put on the market by Alexandria Real Estate Equities after just over two years of ownership.
Greater Boston’s largest lab landlord said vacancies in its local portfolio topped 7 percent in the fourth quarter, but a revival in life science industry expansion plans points to growth in 2024.
Alexandria Real Estate Equities sold a pair of South Boston parcels to a Boston-based investor and a self-storage facility for just over half what it paid for them.
Eight years of hands-on experience in the life science world was the foundation of Jane Kepros’ career switch, where she now plays a role in shaping the next generation of research facilities.
Dour-sounding statistics about the state of Massachusetts’ life science real estate market should be put into context. Yes, the market has short-term challenges, but it will normalize over the coming years.
As developers rethink plans for additional life science projects, Bulfinch Cos. will swap out a planned lab conversion on hold at the Natick Mall in favor of a pickleball complex.
Double-digit availability rates are the new norm for lab space in Greater Boston, with only the industry hub of East Cambridge avoiding the full force of the market downturn.
MassBio, the industry organization that represents more than 1,600 life science and health care organizations and companies, recently began construction of its first workforce training center, Bioversity.
The state’s biggest biotech landlords may be hitting pause on new developments or, in some cases, abandoning projects entirely. But those headlines haven’t dampened enthusiastic predictions from the life science industry’s leading trade group.
A renovation project designed by Margulies Perruzzi transformed over 64,000 square feet across two floors at 20 Overland St. in Boston’s Fenway neighborhood into BSL-2 lab and open-plan office space.
After continuing to ascend driven by life science industry momentum through the early stages of the COVID era, Greater Boston’s commercial real estate industry felt the gravitational pull of financial markets’ tighter lending standards and industry layoffs in 2022.
Dyer Brown & Assoc. designed signage and graphics at The 105 in South Boston to enhance the brand identity of tenant CRISPR Therapeutics.
As a a group of political leaders, business groups and universities lobbies the Biden administration to pick Massachusetts to be the home of a new advanced health research agency, the New England Council last week asked the federal government to consider New England more broadly.
A new report from commercial real estate brokerage JLL says tenant demand in Greater Boston has fallen by nearly 40 percent this year.
During his visit to Boston yesterday, President Joe Biden touted his push for a cancer “moonshot” and declared that the separate federal infrastructure law his administration is implementing will be “the most significant investment” since President Dwight D. Eisenhower.
Sublease availabilities more than doubled in the second quarter to 916,000 square feet, but commercial developers continue to play the lab card as their best bet for virtually every development site.
